Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Fariba Dehghani

Fariba Dehghani

Director
University of Sydney, Sydney
Australia

Biography

Professor Dehghani is a full time employee in the school of Chemical and Biomolecular Engineering at the University of Sydney. She is the director of ARC Food Processing Training Centre, the Director of Centre of Advanced Food Enginomics, an Associate member of IChemE and a member of ARC College of expert. She has been selected by Engineers Australia as one of the top 50 Engineers for innovation in research in 2016. She has been instrumental in building an interdisciplinary research environment that stimulates the interface and intersect of engineering, science, medicine, pharmacy, and agriculture. As a result of her achievement she has received the 2017 Award of Excellence in Chemical Engineering from Australia New Zealand Federation of Chemical Engineering. Her research team in collaboration with industry partners have worked together to provide pragmatic, cost-effective and environmentally sustainable solutions to a diverse range of issues, with the aim of improving lives

Research Interest

Her research is highly regarded, not only in academia but by industry. She has established long-term collaborations with the food and biotech private sectors and acquired substantive funding from national and international competitive grant applications. She is an inventor on 16 patents, including nine with potential end users. She has mentored more than 45 postgraduates and more than 100 honours and master researchers. She mentors several successful entrepreneurs. As a result the outcomes of her research led to establishment of a start-up Company, Trimph Pty Ltd, in 2015 by receiving over than $2 M fund from a private investor and government. This product has recently received approval from TGA for the clinical application.